Author of the publication

SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022

, , , , , , , , , , , , , , , , , and . Infection, 51 (5): 1531-1539 (2023)
DOI: 10.1007/s15010-023-02052-5

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project, , , , , , , , , and 43 other author(s). Infection, 52 (1): 139-153 (2024)NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs, , , , , , , , , and 1 other author(s). J Exp Med, 204 (4): 893-906 (2007)Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection, , , , , , , , and . Frontiers in Immunology, (February 2018)High Seroprevalence of SARS-CoV-2 in Preschool Children in July 2022, , , , , , , , , and 3 other author(s). Dtsch Arztebl Int, 119 (45): 771-772 (2022)SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022, , , , , , , , , and 8 other author(s). Infection, 51 (5): 1531-1539 (2023)